Moderna (MRNA) Cash from Operations (2018 - 2026)
Moderna (MRNA) reported Cash from Operations of 630000000.0 for Q1 2026, up 39.25% year-over-year from 452430747.92 in Q1 2025, and down 167.74% quarter-over-quarter from 930000000.0 in Q4 2025.
Moderna (MRNA) Cash from Operations (2018 - 2026) Analysis & Trends
Moderna (MRNA) has 9 years of Cash from Operations data on file, last reported at 630000000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 630000000.0, up 39.25% year-over-year; the trailing twelve-month figure through Mar 2026 was 1466000000.0 (up 51.97% YoY), and the FY2025 annual result was 1873000000.0, up 37.65% from the prior year.
- Cash from Operations retreated to 630000000.0 in Q1 2026 per MRNA's latest filing, from 930000000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 2763000000.0 in Q1 2022 and troughed at 1600000000.0 in Q3 2023.
- A 5-year average of 214352941.18 and a median of 847000000.0 in 2025 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2023 and 2025: Cash from Operations plunged 734.92% in 2023, then surged 45.91% in 2025.
- A 5-year view of Cash from Operations shows it stood at 1662000000.0 in 2022, then plunged by 62.58% to 622000000.0 in 2023, then soared by 32.64% to 825000000.0 in 2024, then rose by 12.73% to 930000000.0 in 2025, then plunged by 167.74% to 630000000.0 in 2026.
- Business Quant data shows MRNA's Cash from Operations at 630000000.0 in Q1 2026, 930000000.0 in Q4 2025, and 847000000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Moderna | 25.27 Bn | 20.06 Bn | -566.00 Mn | -630.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -630.00 Mn |
| Mar 31, 2026 | -630.00 Mn |
| Dec 31, 2025 | 930.00 Mn |
| Dec 31, 2025 | 930.00 Mn |
| Sep 30, 2025 | -847.00 Mn |
| Sep 30, 2025 | -847.00 Mn |
| Jun 30, 2025 | -919.00 Mn |
| Jun 30, 2025 | -919.00 Mn |
| Mar 31, 2025 | -1.04 Bn |
| Mar 31, 2025 | -1.04 Bn |
| Dec 31, 2024 | 825.00 Mn |
| Dec 31, 2024 | 825.00 Mn |
| Sep 30, 2024 | -1.57 Bn |
| Sep 30, 2024 | -1.57 Bn |
| Jun 30, 2024 | -1.27 Bn |
| Jun 30, 2024 | -1.27 Bn |
| Mar 31, 2024 | -989.00 Mn |
| Mar 31, 2024 | -989.00 Mn |
| Dec 31, 2023 | 622.00 Mn |
| Dec 31, 2023 | 622.00 Mn |